What You Should Know: – The average price per insulin unit dropped 42%, from $0.33 in 2019 to $0.19, in mid-2024, according to a new
Sohail Malik, VP, Healthcare Solutions, Messagepoint, Inc. For Medicare Advantage Organizations (MAOs), the summer months have historically been defined by the high stakes, tight turnarounds
What You Should Know: – A new study from Mount Sinai researchers has revealed that wearable devices, like smartwatches and fitness trackers, can effectively identify,
A next-generation form of chemotherapy from AstraZeneca and Daiichi Sankyo has won Food and Drug Administration authorization for a form of breast cancer, the first
After several years of investigation, the U.S. Department of Justice filed a civil lawsuit accusing Walgreens of illegally dispensing millions of prescriptions for opioid painkillers
The likely next secretary of state, Sen. Marco Rubio, once said of the World Health Organization: “The WHO is a corrupt, radical institution that was
A recent Nature Medicine research report is sounding an alarm. The risk of developing dementia by the age of 95 is 42%. The finding that
AVIZVA, a health-tech organization that offers a variety of solutions for healthcare enterprises, that it has appoints James Vertino as its new CEO. Model N
EQS Newswire / 17/01/2025 / 10:07 UTC+8 The concept of value investing always withstands the test of time, and CK Life Sciences has demonstrated exceptional
President Biden took a groundbreaking step in proposing to cover GLP-1 obesity medications under Medicare and Medicaid in November. But on Friday, his administration announced that Wegovy,